We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …

Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months)- about 44% of the total increase in longevity -and … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …

environmentally-related taxes and tradable permits is likely to lead to greater technological innovation than more direct forms of … aspects of product and labour market regulation which have implications for technological innovation, such as product and …

linked fields. Our analysis uses 1.8 million U.S. patents and their citation properties to map the innovation network and its … strength. Past innovation network structures are calculated using citation patterns across technology classes during 1975 … predictive power on future innovation after 1995. This pattern is consistent with the idea that when there is more past upstream …

contributes to innovation in source countries. We use changes in the labour mobility legislation within Europe as exogenous …

We investigate the relationship between the presence of migrant inventors and the dynamics of innovation in the …

supply on automation innovation by exploiting an immigrant placement policy in Germany during the 1990s and 2000s. Difference …-in-differences estimates indicate that one additional worker per 1,000 manual and unskilled workers reduces automation innovation by 0 …-skilled workers. Labor market tightness and external demand are plausible mechanisms for the labor-innovation nexus. …